Market Tracker

06/30 8:02am ET

Heron Therapeutics Inc (NASDAQ:HRTX)

18.00
Delayed Data
As of Jun 29
 +0.17 / +0.95%
Today’s Change
15.22
Today|||52-Week Range
42.25
-32.58%
Year-to-Date

Today’s Trading

Previous close17.83
Today’s open17.93
Day’s range17.66 - 18.15
Volume387,243
Average volume (3 months)601,090
Market cap$653.6M
Dividend yield--
Data as of 06/29/2016

Growth & Valuation

Earnings growth (last year)-2.79%
Earnings growth (this year)-20.72%
Earnings growth (next 5 years)+72.27%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.50

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.11+3.03%
SCLNSciClone Pharmaceuti...+0.15+1.15%
KERXKeryx Biopharmaceuti...+0.54+8.68%
XNCRXencor Inc+1.95+11.78%
Data as of 06/29/2016

Financials

Next reporting dateAugust 8, 2016
EPS forecast (this quarter)-$0.94
Annual revenue (last year)$0.00
Annual profit (last year)-$97.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts